Bone densitometry provider CompuMed reported second-quarter revenues of $511,000, up 2.6% compared with the $498,000 posted in the second quarter of fiscal 2001. For the period (end-March 31), the Los Angeles-based company had a net loss of $79,000, compared with a net loss of $239,000 last year.
CompuMed also reported success in its international marketing efforts. The firm posted sales from Europe for the first time during the second quarter, and has also received significant interest in its OsteoGram bone densitometry product from the Chinese market, said president and CEO Herbert Lightstone.
By AuntMinnie.com staff writersMay 15, 2002
Related Reading
CompuMed hires new management team, May 13, 2002
CompuMed revenues dip, February 14, 2002
CompuMed eyes international markets, February 6, 2002
Copyright © 2002 AuntMinnie.com
